Literature DB >> 33888121

Correction to: High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer.

Gerardo Gatti1,2, Courtney Betts3, Darío Rocha4, Maribel Nicola5, Verónica Grupe5, Cecilia Ditada5, Nicolas G Nuñez6, Emiliano Roselli7, Paula Araya7, Jeremías Dutto7, Lucia Boffelli7, Elmer Fernández8,9, Lisa M Coussens3, Mariana Maccioni7.   

Abstract

Entities:  

Year:  2021        PMID: 33888121      PMCID: PMC8061077          DOI: 10.1186/s13058-021-01427-6

Source DB:  PubMed          Journal:  Breast Cancer Res        ISSN: 1465-5411            Impact factor:   6.466


× No keyword cloud information.
Correction to: Breast Cancer Res 23, 40 (2021) https://doi.org/10.1186/s13058-021-01418-7 After publication of the original article [1], the authors identified some errors in the authors’ affiliations list. The correct affiliations are below listed: Lisa M Cussens (3) 3) Department of Cell, Developmental & Cancer Biology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA Elmer Fernández (2, 7) 2) Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) 7) CIDIE-CONICET, Universidad Católica de Córdoba, Córdoba, Argentina Mariana Maccioni (6) 6) Departamento de Bioquímica Clínica, Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba 5000, Argentina The original article has been corrected.
  1 in total

1.  High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer.

Authors:  Gerardo Gatti; Courtney Betts; Darío Rocha; Maribel Nicola; Verónica Grupe; Cecilia Ditada; Nicolas G Nuñez; Emiliano Roselli; Paula Araya; Jeremías Dutto; Lucia Boffelli; Elmer Fernández; Lisa M Coussens; Mariana Maccioni
Journal:  Breast Cancer Res       Date:  2021-03-25       Impact factor: 6.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.